Found: 161
Select item for more details and to access through your institution.
Letter: Role of Helicobacter pylori and metabolic syndrome‐related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 5, p. 660, doi. 10.1111/apt.18124
- By:
- Publication type:
- Article
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?
- Published in:
- Endocrine (1355008X), 2024, v. 85, n. 3, p. 988, doi. 10.1007/s12020-024-03783-7
- By:
- Publication type:
- Article
Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 4, p. 540, doi. 10.1111/apt.18066
- By:
- Publication type:
- Article
Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease.
- Published in:
- Endocrine (1355008X), 2024, v. 85, n. 2, p. 704, doi. 10.1007/s12020-024-03769-5
- By:
- Publication type:
- Article
Animal studies of sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease.
- Published in:
- Annals of Gastroenterology, 2024, v. 37, n. 3, p. 280, doi. 10.20524/aog.2024.0884
- By:
- Publication type:
- Article
Circulating leptin in patients with nonalcoholic fatty liver disease‐related liver fibrosis: a systematic review and a meta‐analysis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 5, p. 806, doi. 10.1111/jgh.16480
- By:
- Publication type:
- Article
Impact of Helicobacter pylori and metabolic syndrome-related mast cell activation on cardiovascular diseases.
- Published in:
- Frontiers in Gastroenterology (Frontiers Media S.A.), 2024, p. 1, doi. 10.3389/fgstr.2024.1331330
- By:
- Publication type:
- Article
The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 2, p. 365, doi. 10.1007/s00198-023-06931-3
- By:
- Publication type:
- Article
Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 11/12, p. 1252, doi. 10.1111/apt.17760
- By:
- Publication type:
- Article
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5306, doi. 10.3390/cancers15215306
- By:
- Publication type:
- Article
The Five-Year Effect of a Single Zoledronate Infusion on Bone Mineral Density Following Denosumab Discontinuation in Women with Postmenopausal Osteoporosis.
- Published in:
- Calcified Tissue International, 2023, v. 113, n. 4, p. 469, doi. 10.1007/s00223-023-01119-7
- By:
- Publication type:
- Article
Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 18, p. 5874, doi. 10.3390/jcm12185874
- By:
- Publication type:
- Article
Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case–control study.
- Published in:
- Endocrine (1355008X), 2023, v. 81, n. 3, p. 573, doi. 10.1007/s12020-023-03402-x
- By:
- Publication type:
- Article
Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease.
- Published in:
- Minerva Endocrinology, 2023, v. 48, n. 3, p. 346, doi. 10.23736/S2724-6507.21.03564-8
- By:
- Publication type:
- Article
Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 16, p. 5430, doi. 10.3390/jcm12165430
- By:
- Publication type:
- Article
Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 8, p. 710, doi. 10.1111/jvh.13836
- By:
- Publication type:
- Article
Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome.
- Published in:
- Journal of Neurogastroenterology & Motility, 2023, v. 29, n. 3, p. 403, doi. 10.5056/jnm23061
- By:
- Publication type:
- Article
Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 7, p. 1148, doi. 10.3390/jpm13071148
- By:
- Publication type:
- Article
Association between Helicobacter pylori Infection and Nasal Polyps: A Systematic Review and Meta-Analysis.
- Published in:
- Microorganisms, 2023, v. 11, n. 6, p. 1581, doi. 10.3390/microorganisms11061581
- By:
- Publication type:
- Article
higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1186, doi. 10.1111/apt.17484
- By:
- Publication type:
- Article
Innate immunity and nonalcoholic fatty liver disease.
- Published in:
- Annals of Gastroenterology, 2023, v. 36, n. 3, p. 244, doi. 10.20524/aog.2023.0793
- By:
- Publication type:
- Article
Potential Impact of Helicobacter pylori-Related Metabolic Syndrome on Arterial Hypertension Outcomes.
- Published in:
- American Journal of Hypertension, 2023, v. 36, n. 4, p. 192, doi. 10.1093/ajh/hpac120
- By:
- Publication type:
- Article
Controlling the Impact of Helicobacter pylori -Related Hyperhomocysteinemia on Neurodegeneration.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 3, p. 504, doi. 10.3390/medicina59030504
- By:
- Publication type:
- Article
Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 2, p. 701, doi. 10.1007/s10620-022-07642-1
- By:
- Publication type:
- Article
Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease.
- Published in:
- Therapeutics & Clinical Risk Management, 2023, v. 19, p. 77, doi. 10.2147/TCRM.S352008
- By:
- Publication type:
- Article
Circulating adiponectin in patients with nonalcoholic fatty liver disease‐related liver fibrosis: A systematic review and a meta‐analysis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 10, p. 1853, doi. 10.1111/jgh.15926
- By:
- Publication type:
- Article
Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1702, doi. 10.1111/dom.14774
- By:
- Publication type:
- Article
Emerging parameters relevant to the management of antimicrobial‐resistant Helicobacter pylori infection.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 9, p. 1654, doi. 10.1111/imj.15872
- By:
- Publication type:
- Article
Diagnostic approach to Helicobacter pylori-related gastric oncogenesis.
- Published in:
- Annals of Gastroenterology, 2022, v. 35, n. 4, p. 333, doi. 10.20524/aog.2022.0725
- By:
- Publication type:
- Article
Combination Therapies for Nonalcoholic Fatty Liver Disease.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 7, p. 1166, doi. 10.3390/jpm12071166
- By:
- Publication type:
- Article
GM‐CSF as a potential candidate of a vaccine‐induced reduction of Helicobacter pylori infection.
- Published in:
- Helicobacter, 2022, v. 27, n. 3, p. 1, doi. 10.1111/hel.12884
- By:
- Publication type:
- Article
Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 5, p. 852, doi. 10.1093/ecco-jcc/jjab212
- By:
- Publication type:
- Article
Hypophosphatasia.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 23, p. 5676, doi. 10.3390/jcm10235676
- By:
- Publication type:
- Article
Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 11, p. 3002, doi. 10.1111/jgh.15631
- By:
- Publication type:
- Article
Impact of Helicobacter pylori -Related Metabolic Syndrome Parameters on Arterial Hypertension.
- Published in:
- Microorganisms, 2021, v. 9, n. 11, p. 2351, doi. 10.3390/microorganisms9112351
- By:
- Publication type:
- Article
Review article: non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 8, p. 1013, doi. 10.1111/apt.16575
- By:
- Publication type:
- Article
The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 10, p. e4155, doi. 10.1210/clinem/dgab321
- By:
- Publication type:
- Article
Impact of Helicobacter pylori-related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders.
- Published in:
- Journal of Neurogastroenterology & Motility, 2021, v. 27, n. 4, p. 653, doi. 10.5056/jnm21059
- By:
- Publication type:
- Article
Ιrisin levels in postmenopausal women with an incident hip fracture.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Helicobacter pylori -Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients.
- Published in:
- Microorganisms, 2021, v. 9, n. 7, p. 1361, doi. 10.3390/microorganisms9071361
- By:
- Publication type:
- Article
Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation.
- Published in:
- Calcified Tissue International, 2021, v. 108, n. 5, p. 587, doi. 10.1007/s00223-020-00785-1
- By:
- Publication type:
- Article
A potential impact of Helicobacter pylori‐related sarcopenia on severity of portal hypertension.
- Published in:
- Liver International, 2021, v. 41, n. 5, p. 1168, doi. 10.1111/liv.14777
- By:
- Publication type:
- Article
Update on the association between non‐alcoholic fatty liver disease and Helicobacter pylori infection.
- Published in:
- International Journal of Clinical Practice, 2021, v. 75, n. 4, p. 1, doi. 10.1111/ijcp.13737
- By:
- Publication type:
- Article
Helicobacter pylori, Sleeve Gastrectomy, and Gastroesophageal Reflux Disease: Is There a Relation?
- Published in:
- 2021
- By:
- Publication type:
- Letter
Gastrointestinal and hepatobiliary disorders of patients from countries with low to middle income: a retrospective observational study in a Swiss emergency department.
- Published in:
- Archives of Medical Science. Civilization Diseases, 2021, v. 6, n. 1, p. e36, doi. 10.5114/amscd.2021.105524
- By:
- Publication type:
- Article
A mutation in NOTCH2 gene first associated with Hajdu–Cheney syndrome in a Greek family: diversity in phenotype and response to treatment.
- Published in:
- Endocrine (1355008X), 2021, v. 71, n. 1, p. 208, doi. 10.1007/s12020-020-02446-7
- By:
- Publication type:
- Article
Impact of Helicobacter pylori- related Metabolic Syndrome and Gastroesophageal Reflux Disease on the Risk of Acute Myocardial Infarction.
- Published in:
- Journal of Neurogastroenterology & Motility, 2021, v. 27, n. 1, p. 147, doi. 10.5056/jnm20244
- By:
- Publication type:
- Article
Correction to: A mutation in NOTCH2 gene first associated with Hajdu–Cheney syndrome in a Greek family: diversity in phenotype and response to treatment.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice